Scott Tarriff's Net Worth
$49.1 Million
Who is Scott Tarriff?
Scott Tarriff has an estimated net worth of $49.1 Million. This is based on reported shares across multiple companies, which include ZIOPHARM ONCOLOGY INC, EAGLE PHARMACEUTICALS, INC., Synthetic Biologics, Inc., and CLINICAL DATA INC.
SEC CIK
Scott Tarriff's CIK is 0001469124
Past Insider Trading and Trends
2016 was Scott Tarriff's most active year for acquiring shares with 6 total transactions. Scott Tarriff's most active month to acquire stocks was the month of November. 2015 was Scott Tarriff's most active year for disposing of shares, totalling 23 transactions. Scott Tarriff's most active month to dispose stocks was the month of January. 2018 saw Scott Tarriff paying a total of $961,148.32 for 790,108 shares, this is the most they've acquired in one year. In 2015 Scott Tarriff cashed out on 216,222 shares for a total of $12,538,599.60, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
ZIOPHARM ONCOLOGY INC (TCRT) Snapshot price: $2.83
InvestorScott Tarriff owns 4,186 units of Common Stock which is worth $11,846.38.acquired a total of 4,186 shares in ZIOPHARM ONCOLOGY INC.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 31
| |||
Form 4
|
∞
| 4.19K |
—
|
—
| 4.19K |
Sep 25
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
EAGLE PHARMACEUTICALS, INC. (EGRX) Snapshot price: $5.33
CEOScott Tarriff owns 1,669,622 units of Common Stock, $0.001 par value which is worth $8,899,085.26, 460,621 units of Common Stock which is worth $2,455,109.93 and 1,500,202 units of Commn Stock which is worth $7,996,076.66. From 2014 to 2024 Scott Tarriff acquired a total of 704,607 shares in EAGLE PHARMACEUTICALS, INC. at a cost of $1,235,093.10, Scott also disposed a total of 635,556 shares of EAGLE PHARMACEUTICALS, INC. equalling to $29,138,337.38.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -0.46% | -2.12K |
$6.27 | -$13,286.13 | 460.62K |
Feb 28
| |||
Form 4
| +2.16% | 9.8K |
$6.44 | -$20,311.76 | 462.74K |
Feb 27
| |||
Form 4
| -0.79% | -4.32K |
$5.13 | -$22,171.86 | 541.13K |
Jan 5
| |||
Form 4
| -3.81% | -21.62K |
$13.84 | -$299,309.28 | 545.45K |
Scheduled
|
Nov 1 - Nov 2
| ||
Form 4
| -3.45% | -20.25K |
$14.82 | -$300,026.47 | 567.07K |
Oct 2 - Oct 3
| |||
Form 4
| -2.49% | -15.00K |
$19.98 | -$299,700.00 | 587.31K |
May 16
| |||
Form 4
| -2.74% | -45.00K |
$20.68 | -$930,656.37 | 1.59M |
May 11 - May 15
| |||
Form 4
| +4.31% | 67.79K |
$28.00 | -$87,164.00 | 1.64M |
Feb 28 - Mar 1
| |||
Form 4
| -0.24% | -3.73K |
$33.64 | -$125,544.48 | 1.57M |
Jan 23
| |||
Form 4
| -0.24% | -3.83K |
$29.26 | -$111,978.02 | 1.58M |
Jan 5
| |||
Form 4
| +2.25% | 34.8K |
—
|
—
| 1.58M |
Feb 28
| |||
Form 4
| -0.09% | -1.42K |
$25.33 | -$407,615.08 | 1.54M |
Feb 23 - Apr 1
| |||
Form 4
| -0.30% | -4.63K |
$47.70 | -$220,898.70 | 1.55M |
Jan 23
| |||
Form 4
| -0.48% | -7.55K |
$57.98 | -$437,633.04 | 1.55M |
Jan 23
| |||
Form 4
| +3.89% | 58.3K |
—
|
—
| 1.56M |
Jan 5
| |||
Form 4
| -1.64% | -24.98K |
$50.15 | -$1,252,496.25 | 1.5M |
Scheduled
|
Apr 1
| ||
Form 4
| -1.58% | -24.43K |
$51.17 | -$1,250,014.68 | 1.53M |
Scheduled
|
Mar 1
| ||
Form 4
| -1.90% | -30.09K |
$41.54 | -$1,249,831.20 | 1.55M |
Scheduled
|
Feb 1
| ||
Form 4
| +4.04% | 61.3K |
—
|
—
| 1.58M |
Jan 23
| |||
Form 4
| -2.04% | -31.57K |
$39.49 | -$1,246,763.02 | 1.52M |
Scheduled
|
Jan 2 - Jan 3
| ||
Form 4
| +8.76% | 124.8K |
$4.04 | $504,208.16 | 1.55M |
Jun 28
| |||
Form 4
| +4.03% | 55.21K |
$28.37 | -$2,593,547.39 | 1.43M |
Mar 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 4
| |||
Form 4
| -2.20% | -30.77K |
$40.63 | -$1,249,981.95 | 1.37M |
Scheduled
|
Apr 1
| ||
Form 4
| -1.39% | -19.78K |
$63.20 | -$1,250,027.96 | 1.4M |
Scheduled
|
Mar 1
| ||
Form 4
| -1.28% | -18.36K |
$68.08 | -$1,249,974.34 | 1.42M |
Scheduled
|
Feb 1
| ||
Form 4
| -1.00% | -14.55K |
$85.91 | -$1,249,920.86 | 1.44M |
Scheduled
|
Jan 4
| ||
Form 4
| -0.96% | -14.05K |
$88.93 | -$1,249,418.92 | 1.45M |
Scheduled
|
Dec 1
| ||
Form 4
| -1.30% | -19.34K |
$64.63 | -$1,249,954.91 | 1.47M |
Scheduled
|
Nov 2
| ||
Form 4
| -1.19% | -17.88K |
$69.92 | -$1,249,964.73 | 1.49M |
Scheduled
|
Oct 1
| ||
Form 4
| -1.07% | -16.25K |
$76.95 | -$1,249,998.04 | 1.5M |
Scheduled
|
Sep 1
| ||
Form 4
| -0.85% | -13.00K |
$96.19 | -$1,250,408.26 | 1.52M |
Scheduled
|
Aug 3
| ||
Form 4
| -8.13% | -135.71K |
$46.34 | -$6,288,854.74 | 1.53M |
Scheduled
|
Mar 20 - Jul 1
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 26
| |||
Form 4
| +13.40% | 197.25K |
—
|
—
| 1.67M |
Feb 18
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Synthetic Biologics, Inc. (TOVX) Snapshot price: $4.37
InvestorScott Tarriff owns 300,000 units of Common Stock which is worth $1,311,000.00. In the year 2012 Scott Tarriff acquired a total of 300,000 shares in Synthetic Biologics, Inc..
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 30
| |||
Form 4
|
∞
| 300K |
—
|
—
| 300K |
Nov 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 5
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
CLINICAL DATA INC No price found
InvestorScott Tarriff used to own units in Common Stock but no longer holds any shares there. In the year 2009 Scott Tarriff filed a total of 5 filings.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -16.60K |
$30.00 | -$498,000.00 |
0
|
Apr 12 - Apr 13
| |||
Form 4
| +84.44% | 7.6K |
—
|
—
| 16.6K |
Sep 16
| |||
Form 3/A
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
∞
| 9K |
—
|
—
| 9K |
Sep 17
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||